CapsoVision (CV) director receives 4,045 RSU grant as board compensation

Rhea-AI Filing Summary

King Wen-Herng Henry reported acquisition or exercise transactions in this Form 4 filing.

CapsoVision, Inc director King Wen-Herng Henry reported receiving a grant of 4,045 Restricted Stock Units (RSUs) tied to the company’s common stock. Each RSU represents a contingent right to receive one share of common stock if vesting conditions are met.

The award is scheduled to vest in two equal tranches, with 50% vesting on June 30, 2026 and the remaining 50% vesting on December 31, 2026, subject to his continued service on the board through each vesting date. Following this grant, his reported direct holdings consist of 4,045 RSUs.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider King Wen-Herng Henry

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit (RSU)	4,045	$0.00	--

Holdings After Transaction: Restricted Stock Unit (RSU) — 4,045 shares (Direct)

Footnotes (1)

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

King Wen-Herng Henry

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	(1)	03/19/2026		A		4,045		(2)	(2)	Common Stock	4,045	$0	4,045	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Wen-Herng Henry King	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CapsoVision (CV) disclose for King Wen-Herng Henry?

CapsoVision disclosed that director King Wen-Herng Henry received 4,045 Restricted Stock Units (RSUs). These RSUs are a stock-based compensation award and represent a contingent right to receive an equal number of CapsoVision common shares if vesting conditions are satisfied.

How many CapsoVision (CV) RSUs did the director receive in this Form 4?

The director was granted 4,045 Restricted Stock Units. Each RSU corresponds to one potential share of CapsoVision common stock, so the grant covers 4,045 underlying shares, contingent on future vesting and continued board service through the specified dates.

What is the vesting schedule for the 4,045 CapsoVision (CV) RSUs?

The 4,045 RSUs vest in two equal installments. Half of the award vests on June 30, 2026, and the remaining half vests on December 31, 2026, provided the non-employee director continues serving on the CapsoVision board through each vesting date.

Does this CapsoVision (CV) Form 4 represent a market purchase or sale?

No, this Form 4 reflects a grant of 4,045 RSUs as compensation, not an open-market trade. The transaction code is “A,” indicating a grant or award acquisition, with a reported price of $0.0000 per unit rather than a market purchase or sale.

What does each CapsoVision (CV) RSU in this filing represent?

Each RSU represents a contingent right to receive one share of CapsoVision common stock. The director does not receive actual shares until the RSUs vest, and vesting depends on continued board service through the scheduled vesting dates in 2026.

What are King Wen-Herng Henry’s reported holdings after this CapsoVision (CV) RSU grant?

After this transaction, the filing shows the director holding 4,045 RSUs directly. These RSUs correspond to 4,045 underlying shares of CapsoVision common stock that may be delivered if the award’s vesting conditions are fully met over time.